These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 16905558)
1. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Thakkinstian A; Han P; McEvoy M; Smith W; Hoh J; Magnusson K; Zhang K; Attia J Hum Mol Genet; 2006 Sep; 15(18):2784-90. PubMed ID: 16905558 [TBL] [Abstract][Full Text] [Related]
2. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728 [TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population. Soysal Y; Inan UÜ; Küsbeci T; Imirzalioğlu N DNA Cell Biol; 2012 Mar; 31(3):323-30. PubMed ID: 21790300 [TBL] [Abstract][Full Text] [Related]
4. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration. Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration. Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788 [TBL] [Abstract][Full Text] [Related]
6. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis. Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y Sci Rep; 2015 Sep; 5():14517. PubMed ID: 26411831 [TBL] [Abstract][Full Text] [Related]
8. Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort. Sharma NK; Gupta A; Prabhakar S; Singh R; Sharma SK; Chen W; Anand A PLoS One; 2013; 8(7):e70193. PubMed ID: 23922956 [TBL] [Abstract][Full Text] [Related]
9. Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis. Quan YL; Zhou AY; Feng ZH Int J Ophthalmol; 2012; 5(2):242-6. PubMed ID: 22762059 [TBL] [Abstract][Full Text] [Related]
10. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663 [TBL] [Abstract][Full Text] [Related]
11. Clinical study of the correlation between complement factor H polymorphism and age-related macular degeneration. Dong HT; Zhang JX; Li QM; Li FZ Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706724 [TBL] [Abstract][Full Text] [Related]
12. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M Int Ophthalmol; 2017 Dec; 37(6):1397-1409. PubMed ID: 28005184 [TBL] [Abstract][Full Text] [Related]
13. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis. Roshanshad A; Moosavi SA; Arevalo JF Ophthalmic Res; 2024; 67(1):358-386. PubMed ID: 38754401 [TBL] [Abstract][Full Text] [Related]
14. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302 [TBL] [Abstract][Full Text] [Related]
15. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration]. Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491 [TBL] [Abstract][Full Text] [Related]
16. Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis. Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M; Karimi S Curr Eye Res; 2016 Dec; 41(12):1519-1525. PubMed ID: 27269047 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Baird PN; Islam FM; Richardson AJ; Cain M; Hunt N; Guymer R Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4194-8. PubMed ID: 17003406 [TBL] [Abstract][Full Text] [Related]
18. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Lau LI; Chen SJ; Cheng CY; Yen MY; Lee FL; Lin MW; Hsu WM; Wei YH Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3242-6. PubMed ID: 16877387 [TBL] [Abstract][Full Text] [Related]
19. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study. Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675 [TBL] [Abstract][Full Text] [Related]
20. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]